Nimbus technology enters Indian wound care market via Microfoam launch
Quick-Med Technologies' commercialisation partner, Viridis BioPharma, has begun selling and shipping Microfoam dressings to its customers. Microfoam is the first advanced wound care dressing to employ Quick-Med's proprietary non-leaching Nimbus technology. Viridis received approval by India's FDA in September 2011 to manufacture and market Microfoam wound dressings incorporating Nimbus antimicrobial technology.
Nimbus technology is intended to prevent the transmission of virulent bacteria, such as Methicillin-resistant Staphylococcus aureus, and is believed to be the first non-leaching antimicrobial available in a wound dressing. Nimbus technology is designed to prevent bacteria developing resistance, and avoid releasing toxic material into the wound, so there is no impeding the wound healing process. It is also effective in high concentrations of body fluids.